Byron Myers - Inogen Co-Founder and VP of Marketing
INGN Stock | USD 6.70 0.05 0.74% |
Founder
Mr. Byron Myers is Executive Vice President of Sales and Marketing of Inogen, Inc., Mr. Myers is a cofounder of Inogen and has served as our Executive Vice President, Engineering since March 2014. Prior to serving in this position, Mr. Taylor served as our Vice President, Engineering from 2008 until March 2014 and as the Director of Technology with our company from 2003 to 2008. Mr. Taylor is listed as an inventor on 28 of the Companys issued U.S. patents related to portable oxygen concentrator development since 2017.
Age | 38 |
Tenure | 7 years |
Address | 859 Ward Drive, Goleta, CA, United States, 93111 |
Phone | 805 562 0500 |
Web | https://www.inogen.com |
Inogen Management Efficiency
The company has return on total asset (ROA) of (0.1091) % which means that it has lost $0.1091 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.408) %, meaning that it created substantial loss on money invested by shareholders. Inogen's management efficiency ratios could be used to measure how well Inogen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of April 2024, Return On Tangible Assets is likely to grow to -0.35. In addition to that, Return On Capital Employed is likely to grow to -0.24. At this time, Inogen's Deferred Long Term Asset Charges is very stable compared to the past year. As of the 23rd of April 2024, Intangibles To Total Assets is likely to grow to 0.14, while Total Assets are likely to drop about 292 M.Similar Executives
Found 1 records | FOUNDER Age | ||
Jason Krantz | Definitive Healthcare Corp | 50 |
Management Performance
Return On Equity | -0.41 | ||||
Return On Asset | -0.11 |
Inogen Inc Leadership Team
Elected by the shareholders, the Inogen's board of directors comprises two types of representatives: Inogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inogen. The board's role is to monitor Inogen's management team and ensure that shareholders' interests are well served. Inogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael Bourque, CFO VP | ||
Scott Beardsley, Director | ||
Bart Sanford, Executive Vice President Operations | ||
Agnes Lee, VP Planning | ||
Philip Corrin, Senior Chain | ||
Jason Somer, General VP | ||
Jennifer Boyer, Executive Officer | ||
Kevin Smith, CEO President | ||
Scott Greer, Independent Director | ||
Benjamin AndersonRay, Independent Director | ||
Scott Wilkinson, Pres and COO | ||
Brenton Taylor, Co-Founder and Executive VP of Engineering | ||
MBA MD, Executive Officer | ||
Kristin Caltrider, CFO VP | ||
Raymond Huggenberger, CEO and Director | ||
Heath Lukatch, Independent Chairman of the Board | ||
Matthew Scribner, Executive Vice President - Operations | ||
Alison Bauerlein, Co-Founder, CFO, Principal Accounting Officer, Executive VP of Fin., Treasurer and Secretary | ||
Nabil Shabshab, Pres CEO | ||
Vijay Paliwal, Senior Enablement | ||
Heather Rider, Director | ||
Michael Sergesketter, Chief President | ||
Loren McFarland, Independent Director | ||
George Parr, Ex Officer | ||
Matthew Pigeon, Investor Officer | ||
Byron Myers, Co-Founder and VP of Marketing | ||
Grgoire Ramade, Executive Officer |
Inogen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Inogen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.41 | ||||
Return On Asset | -0.11 | ||||
Profit Margin | (0.32) % | ||||
Operating Margin | (0.29) % | ||||
Current Valuation | 50.91 M | ||||
Shares Outstanding | 23.55 M | ||||
Shares Owned By Insiders | 0.91 % | ||||
Shares Owned By Institutions | 93.88 % | ||||
Number Of Shares Shorted | 1.69 M | ||||
Price To Earning | 61.63 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Inogen Inc information on this page should be used as a complementary analysis to other Inogen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Inogen Stock analysis
When running Inogen's price analysis, check to measure Inogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inogen is operating at the current time. Most of Inogen's value examination focuses on studying past and present price action to predict the probability of Inogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inogen's price. Additionally, you may evaluate how the addition of Inogen to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Inogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.873 | Earnings Share (4.42) | Revenue Per Share 13.62 | Quarterly Revenue Growth (0.14) | Return On Assets (0.11) |
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.